Congress Materials – American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM 2024)

This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.

Adverse pregnancy outcomes in myasthenia gravis: A retrospective cohort study in a US health insurance claims database

Melanie H. Jacobson, Rupa Makadia, John Sheehan, Nathan Hall, Jill Hardin, Sicong Huang, Ran Sun, Rebecca Zaha, Alexis A. Krumme

 

View poster

Assessing the suitability of the Neuro-QoL Fatigue to evaluate fatigue in patients living with Myasthenia Gravis

Sheryl Pease, Kayla Scippa

 

View poster

Efficacy and Safety of Nipocalimab in Patients with Generalized Myasthenia Gravis: Topline Results from the Double-Blind, Placebo-Controlled, Randomized Phase 3 Vivacity-MG3 Study

Tuan Vu, Carlo Antozzi, Sindhu Ramchandren, Richard J. Nowak, Constantine Farmakidis, Vera Bril, Jan De Bleecker, Huan Yang, Eduard Minks, Jin-Sung Park, Mariusz Grudniak, Marek Smilowski, Teresa Sevilla, Sarah Hoffmann, Kumaraswamy Sivakumar, Eriene Youssef, Panna Sanga, Keith Karcher, Yaowei Zhu, Leona E. Ling, Hong Sun

 

View poster

Factors influencing exacerbations and crisis in generalized myasthenia gravis: Findings from a claims database study

Louis Jackson, Zhiwen Liu, Jacqueline Pesa, Alicia K Campbell, Zia Choudhry, Alberto E Batista, Qian Cai, Nizar Souayah

 

View poster

Interim results for Myasthenia Gravis-Resource Utilization, Epidemiology, Survival & Treatment Patterns (MG-REST) study in Ontario, Canada

Carolina Barrnett-Tapia, Kobina Quansah, Aysegul Erman, Ryan Ng, Nikhil Nath, Arushi Sharma

 

View poster

Leveraging AI to characterize mental health experiences throughout the Myasthenia Gravis diagnosis journey

Raghav Govindarajan, Rachelle D. Rodriguez, Zia Choudhry, Caroline Brethenoux, Jacqui Pesa, Sindhu Ramchandren, Nolan Campbell, Kavita Gandhi, Kristin Heerlein, Nizar Souayah, Ashley E.L. Anderson

 

View poster

Perinatal treatment patterns in myasthenia gravis

Melanie H. Jacobson, Rupa Makadia, Anna Ostropolets, John Sheehan, Sicong Huang, Rebecca Zaha, Alexis A. Krumme

 

View poster

Safety and effectiveness of nipocalimab in adolescent participants in the open label Phase 2/3 VIBRANCE-MG clinical study

Jonathan Strober, Shawn Black, Sindhu Ramchandren, Saunder Bernes, Akiyuki Uzawa, Yasuhiro Kimoto, Keiko Ishigaki, Tuan Vu, Dan Huang, Yaowei Zhu, Hong Sun

 

View poster

Treatment Outcomes among Patients with Generalized Myasthenia Gravis in the Czech Republic: Results from MYasthenia gravis REGistry (MyReg)

Stanislav Voháňka, Magda Horáková, Qian Cai, Winghan J. Kwong, Kavita Gandhi, Alberto E. Batista, Jana Baranová, Lenka Mokrá, Michaela Týblová, Jana Junkerová, Edvard Ehler, Hana Matulová, Radim Mazanec, Petr Ridzoň, Shane Kavanagh

 

View poster